Clinical trial
Quality of Erection Study
NCT00159900 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00159900 |
|---|---|
| Title | Quality of Erection Study |
| Official title | A Multicenter, Parallel Group Flexible Dose Study With A Double Blind, Randomized, Placebo Controlled Phase And An Open-Label Phase To Evaluate The Quality Of Erections In Men With Erectile Dysfunction Treated With Sildenafil Citrate |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | Sildenafil Citrate |
| Enrollment | 300 |
| Start date | May 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 1, 2021 |
| Countries | Brazil, Germany, Italy, Poland, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: